News

FDA recently approved a new diabetes medication, as well as a drug to treat severe asthma.

Fitbit devices will be used for an NIH research program to explore the influence of behavioral, biological, and environmental influences on health.

The regulatory landscape for interoperability is changing, according to Mildred Segura, partner at international law firm Reed Smith.

If signed into law, Trump’s tax reform will have substantive impacts on healthcare organizations and on individuals.

Two new studies address the financial implications of unexpected major healthcare expenses for common cardiovascular conditions and procedures.

The American Medical Informatics Associations says interoperability has fallen off as a priority at the ONC. Here are its top recommendations to the organization.

The COPD executive care team at Sanford Medical Center is leading to impressive results. Find out who is part of the team and how it works.

Soon after FDA approved a novel device to treat opioid use disorder, FDA approved the first and only once-monthly injectable buprenorphine formulation to treat moderate to severe opioid use disorder (OUD).

Healthcare executives have a unique leadership role to play in addressing the opioid crisis. Here’s what you need to do now.

A new biosimilar to the cancer drug Herceptin, which raked in $2.5 billion in US sales last year, is expected to produce blockbuster sales in the US.

Experts weigh in on the findings from Managed Healtcare Executive’s 2017 State of the Industry Survey.

Treating RA is a work in progress. Here’s what you need to know.

FDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.

Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.

Gender bias in patient care has damaging effects, especially for women.

Here are six healthcare impact trends that will challenge marketers in the upcoming year.

Autologous stem cell therapy may offer hope for patients with COPD. But some say caution is necessary.

Experts share more about Alex Azar’s background and predict what his top agenda items are likely to be.

A new study led by UCLA researchers has eye-opening findings about low-cost, high-volume unnecessary healthcare. These low-value services may surprise you.

A new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.

The key changes the Trump Administration has made that could make it more difficult for consumers to sign up for healthcare coverage.

A commercial health plan analysis by axialHealthcare has interesting findings about funding opioid use disorder treatment plans.

Here’s how health systems can provide patients with ways to improve their overall financial experience as the frustration around high-deductible health plans continue to encourage patient consumerism.

Plans must be able to deploy these five tactics, whether using internal resources or collaborating with a vendor.

A new survey from SAP/Oxford Economics has eye-opening findings about the progress of healthcare’s digital transformations.

Two patient survey studies sponsored by Mallinckrodt reveal findings about patient-reported multiple sclerosis rates.

Allergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.

A Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.